跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 12,655 条关于
“CER Groupe”
全部
12,655
临床试验
8,264
药物
2,405
机构
423
资讯
1,563
去年
Genflow Biosciences Advances SIRT6 Gene Therapy Pipeline with Strategic Partnerships and Patent Expansion
去年
FDA Clears CERo Therapeutics' IND for Novel CAR-T Therapy CER-1236 in Solid Tumors
去年
CERo Therapeutics Advances Novel CER-T Cell Therapy for AML with Invivoscribe Diagnostic Support
去年
CERo Therapeutics' CER-1236 Shows Promise in Preclinical Ovarian Cancer Models
去年
EMA Provides Positive Feedback on ABIONYX Pharma's CER-001 for LCAT Deficiency
去年
CERo Therapeutics Secures $5M Funding, Advances Novel CER-T Cell Therapy Towards Phase 1 Trial
上个月
Lundbeck Reports 16% CER Revenue Growth in H1 2026, Driven by Vyepti and Advancing Pipeline
去年
CERo Therapeutics' CER-1236 Receives FDA Clearance for Phase 1 AML Trial
去年
CERo Therapeutics Receives FDA Clearance for CER-1236 AML Clinical Trial
2个月前
ABIONYX Secures Up to €33M and Launches Pivotal Phase 2b Trial of CER-001 in Sepsis
第 1 页,共 157 页
上一页
下一页